BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 29164341)

  • 1. Mathematical Models of HIV Latency.
    Hill AL
    Curr Top Microbiol Immunol; 2018; 417():131-156. PubMed ID: 29164341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical Models of HIV-1 Dynamics, Transcription, and Latency.
    D'Orso I; Forst CV
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Latent Reservoir for HIV-1.
    Sengupta S; Siliciano RF
    Immunity; 2018 May; 48(5):872-895. PubMed ID: 29768175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy.
    Wang S; Rong L
    J Theor Biol; 2014 Nov; 360():137-148. PubMed ID: 25016044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stochastic Dynamics of the Latently Infected Cell Reservoir During HIV Infection.
    Azoz SA; Coombs D
    Bull Math Biol; 2019 Jan; 81(1):131-154. PubMed ID: 30298198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
    Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What can we do to reduce the viral reservoir in HIV-1-infected individuals?
    Pohlmeyer CW; Walker-Sperling VE; Blankson JN
    Future Microbiol; 2016 Jul; 11():839-42. PubMed ID: 27416850
    [No Abstract]   [Full Text] [Related]  

  • 8. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy.
    Jones LE; Perelson AS
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):483-93. PubMed ID: 17496565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling HIV persistence, the latent reservoir, and viral blips.
    Rong L; Perelson AS
    J Theor Biol; 2009 Sep; 260(2):308-31. PubMed ID: 19539630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of viral reservoirs in HIV-1 infection.
    Blankson JN; Persaud D; Siliciano RF
    Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
    Sedaghat AR; Siliciano RF; Wilke CO
    BMC Infect Dis; 2008 Jan; 8():2. PubMed ID: 18171475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips.
    Rong L; Perelson AS
    Math Biosci; 2009 Jan; 217(1):77-87. PubMed ID: 18977369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underlying mechanisms of HIV-1 latency.
    Romani B; Allahbakhshi E
    Virus Genes; 2017 Jun; 53(3):329-339. PubMed ID: 28258391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment].
    Llibre JM; Martínez-Picado J
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():17-22. PubMed ID: 19572421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.
    Sedaghat AR; Siliciano JD; Brennan TP; Wilke CO; Siliciano RF
    PLoS Pathog; 2007 Aug; 3(8):e122. PubMed ID: 17784786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards an HIV-1 cure: measuring the latent reservoir.
    Bruner KM; Hosmane NN; Siliciano RF
    Trends Microbiol; 2015 Apr; 23(4):192-203. PubMed ID: 25747663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Eradication Strategies: Implications for the Central Nervous System.
    Veenhuis RT; Clements JE; Gama L
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):96-104. PubMed ID: 30734905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
    Chun TW; Justement JS; Moir S; Hallahan CW; Maenza J; Mullins JI; Collier AC; Corey L; Fauci AS
    J Infect Dis; 2007 Jun; 195(12):1762-4. PubMed ID: 17492591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.